Young Matthew P. 4
4 · Jazz Pharmaceuticals plc · Filed Feb 27, 2019
Insider Transaction Report
Form 4
Young Matthew P.
EVP & CFO
Transactions
- Tax Payment
Ordinary Shares
[F1][F2]2019-02-25$126.25/sh−1,218$153,773→ 30,917 total - Sale
Ordinary Shares
[F3]2019-02-26$125.93/sh−1,032$129,960→ 29,885 total - Tax Payment
Ordinary Shares
[F1]2019-02-26$127.76/sh−1,034$132,104→ 28,851 total - Sale
Ordinary Shares
[F3]2019-02-27$137.91/sh−884$121,912→ 27,967 total
Footnotes (3)
- [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- [F2]Includes 67 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Signature
By: /s/Peter A Christou, as attorney in fact For: Matthew Paul Young|2019-02-27